Latest Breaking News On - Life sciences company profile - Page 1 : comparemela.com

ENDRA Life Sciences Inc (NASDAQ:NDRA) Sees Large Growth in Short Interest

ENDRA Life Sciences Inc. (NASDAQ:NDRA – Get Free Report) was the target of a significant growth in short interest during the month of May. As of May 15th, there was short interest totalling 104,700 shares, a growth of 2,517.5% from the April 30th total of 4,000 shares. Based on an average daily volume of 184,100 […]

Life sciences stock performanceLife sciences company profileLife sciencesLife sciences incEndra life sciences incLife sciences dailyGet free reportSciences stockSciences companySciences incSciences daily

Achieve Life Sciences (NASDAQ:ACHV) Stock Passes Above Two Hundred Day Moving Average of $4 54

Achieve Life Sciences (NASDAQ:ACHV) Stock Passes Above Two Hundred Day Moving Average of $4 54
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesVirtu financialNews ratings for achieve life sciences dailyMadison park capital advisorsLife sciences price performanceRaymond james associatesLife sciencesManchester financial incLife sciences incLife sciences company profileAchieve life sciencesGet free reportStreet capitalSpark capital advisorsAchieve life sciences daily

ENDRA Life Sciences (NDRA) Scheduled to Post Quarterly Earnings on Tuesday

ENDRA Life Sciences (NDRA) Scheduled to Post Quarterly Earnings on Tuesday
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Life sciences incLife sciences company profileEndra life sciencesLife sciencesLife sciences stock downLife sciences dailyGet free reportSciences stock downSciences companySciences incSciences daily

Achieve Life Sciences (NASDAQ:ACHV) Research Coverage Started at Jonestrading

Jonestrading assumed coverage on shares of Achieve Life Sciences (NASDAQ:ACHV – Free Report) in a research report report published on Wednesday morning, Benzinga reports. The firm issued a buy rating and a $20.00 price objective on the biopharmaceutical company’s stock. Several other analysts have also issued reports on ACHV. Lake Street Capital cut their target […]

United kingdomUnited statesMorgan stanleyLife sciences company profileTower research capitalLife sciences incMadison park capital advisorsNews ratings for achieve life sciences dailyLife sciencesPrelude capital managementLife sciences price performanceAchieve life sciencesFree reportStreet capitalResearch capitalSpark capital advisors

Achieve Life Sciences (NASDAQ:ACHV) Stock Rating Reaffirmed by Oppenheimer

Achieve Life Sciences (NASDAQ:ACHV) Stock Rating Reaffirmed by Oppenheimer
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesLife sciences incTower research capitalNews ratings for achieve life sciences dailyMadison park capital advisorsCharles schwab investment management incLife sciences stock downLife sciences company profilePrelude capital managementLife sciencesYork mellon corpAchieve life sciencesFree reportLake street capitalResearch capital